Literature DB >> 28365588

Associations of anthropometry and lifestyle factors with HDL subspecies according to apolipoprotein C-III.

Manja Koch1, Jeremy D Furtado2, Gordon Z Jiang3, Brianna E Gray2, Tianxi Cai4, Frank Sacks2,5, Anne Tjønneland6, Kim Overvad7, Majken K Jensen2,5.   

Abstract

The presence of apoC-III on HDL impairs HDL's inverse association with coronary heart disease (CHD). Little is known about modifiable factors explaining variation in HDL subspecies defined according to apoC-III. The aim was to investigate cross-sectional associations of anthropometry and lifestyle with HDL subspecies in 3,631 participants from the Diet, Cancer, and Health study originally selected for a case-cohort study (36% women; age 50-65 years) who were all free of CHD. Greater adiposity and less activity were associated with higher HDL containing apoC-III and lower HDL lacking apoC-III. Per each 15 cm higher waist circumference, the level of HDL containing apoC-III was 2.8% higher (95% CI: 0.4, 5.3; P = 0.024) and the level of HDL not containing apoC-III was 4.7% lower (95% CI: -6.0, -3.4; P = <0.0001). Associations for physical activity were most robust to multivariable modeling. Each 20 metabolic equivalent task hours per week reported higher physical activity was associated with 0.9% (95% CI: -1.7, -0.1; P = 0.031) lower HDL containing apoC-III and 0.5% higher (95% CI: 0.1, 1.0; P = 0.029) HDL lacking apoC-III. Lower alcohol consumption was associated with lower HDL lacking apoC-III (percent difference per 15 g/day: 1.58 (95% CI: 0.84, 2.32; P = <0.0001). Adiposity and sedentary lifestyle were associated with a less favorable HDL subspecies profile.
Copyright © 2017 by the American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  epidemiology; high density lipoprotein; obesity

Mesh:

Substances:

Year:  2017        PMID: 28365588      PMCID: PMC5454517          DOI: 10.1194/jlr.P073288

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  33 in total

1.  Case definitions for acute coronary heart disease in epidemiology and clinical research studies: a statement from the AHA Council on Epidemiology and Prevention; AHA Statistics Committee; World Heart Federation Council on Epidemiology and Prevention; the European Society of Cardiology Working Group on Epidemiology and Prevention; Centers for Disease Control and Prevention; and the National Heart, Lung, and Blood Institute.

Authors:  Russell V Luepker; Fred S Apple; Robert H Christenson; Richard S Crow; Stephen P Fortmann; David Goff; Robert J Goldberg; Mary M Hand; Allan S Jaffe; Desmond G Julian; Daniel Levy; Teri Manolio; Shanthi Mendis; George Mensah; Andrzej Pajak; Ronald J Prineas; K Srinath Reddy; Veronique L Roger; Wayne D Rosamond; Eyal Shahar; A Richey Sharrett; Paul Sorlie; Hugh Tunstall-Pedoe
Journal:  Circulation       Date:  2003-11-10       Impact factor: 29.690

2.  A comparative study of prescribing of hormone replacement therapy in USA and Europe.

Authors:  J V Jolleys; F Olesen
Journal:  Maturitas       Date:  1996-02       Impact factor: 4.342

3.  Low-density lipoproteins containing apolipoprotein C-III and the risk of coronary heart disease.

Authors:  Carlos O Mendivil; Eric B Rimm; Jeremy Furtado; Stephanie E Chiuve; Frank M Sacks
Journal:  Circulation       Date:  2011-10-10       Impact factor: 29.690

4.  Distinct patterns of lipoproteins with apoB defined by presence of apoE or apoC-III in hypercholesterolemia and hypertriglyceridemia.

Authors:  H Campos; D Perlov; C Khoo; F M Sacks
Journal:  J Lipid Res       Date:  2001-08       Impact factor: 5.922

5.  Alcohol consumption raises HDL cholesterol levels by increasing the transport rate of apolipoproteins A-I and A-II.

Authors:  E R De Oliveira E Silva; D Foster; M McGee Harper; C E Seidman; J D Smith; J L Breslow; E A Brinton
Journal:  Circulation       Date:  2000-11-07       Impact factor: 29.690

6.  Body fat, body fat distribution, lean body mass and atrial fibrillation and flutter. A Danish cohort study.

Authors:  Lars Frost; Emelia J Benjamin; Morten Fenger-Grøn; Asger Pedersen; Anne Tjønneland; Kim Overvad
Journal:  Obesity (Silver Spring)       Date:  2014-02-18       Impact factor: 5.002

7.  Antisense Inhibition of Apolipoprotein C-III in Patients with Hypertriglyceridemia.

Authors:  Daniel Gaudet; Veronica J Alexander; Brenda F Baker; Diane Brisson; Karine Tremblay; Walter Singleton; Richard S Geary; Steven G Hughes; Nicholas J Viney; Mark J Graham; Rosanne M Crooke; Joseph L Witztum; John D Brunzell; John J P Kastelein
Journal:  N Engl J Med       Date:  2015-07-30       Impact factor: 91.245

8.  Study design, exposure variables, and socioeconomic determinants of participation in Diet, Cancer and Health: a population-based prospective cohort study of 57,053 men and women in Denmark.

Authors:  Anne Tjønneland; Anja Olsen; Katja Boll; Connie Stripp; Jane Christensen; Gerda Engholm; Kim Overvad
Journal:  Scand J Public Health       Date:  2007       Impact factor: 3.021

9.  Physical activity and function in older, long-term colorectal cancer survivors.

Authors:  Brent L Johnson; Amy Trentham-Dietz; Kelli F Koltyn; Lisa H Colbert
Journal:  Cancer Causes Control       Date:  2009-01-04       Impact factor: 2.506

10.  Apolipoprotein C-III as a Potential Modulator of the Association Between HDL-Cholesterol and Incident Coronary Heart Disease.

Authors:  Majken K Jensen; Eric B Rimm; Jeremy D Furtado; Frank M Sacks
Journal:  J Am Heart Assoc       Date:  2012-04-24       Impact factor: 5.501

View more
  9 in total

1.  Protein-Defined Subspecies of HDLs (High-Density Lipoproteins) and Differential Risk of Coronary Heart Disease in 4 Prospective Studies.

Authors:  Frank M Sacks; Liang Liang; Jeremy D Furtado; Tianxi Cai; W Sean Davidson; Zeling He; Robyn L McClelland; Eric B Rimm; Majken K Jensen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-09-10       Impact factor: 8.311

Review 2.  From High-Density Lipoprotein Cholesterol to Measurements of Function: Prospects for the Development of Tests for High-Density Lipoprotein Functionality in Cardiovascular Disease.

Authors:  Frank M Sacks; Majken K Jensen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-01-25       Impact factor: 8.311

3.  HDL Containing Apolipoprotein C-III is Associated with Insulin Sensitivity: A Multicenter Cohort Study.

Authors:  Rain Yamamoto; Majken K Jensen; Sarah Aroner; Jeremy D Furtado; Bernard Rosner; Frank B Hu; Beverley Balkau; Andrea Natali; Ele Ferrannini; Simona Baldi; Frank M Sacks
Journal:  J Clin Endocrinol Metab       Date:  2021-07-13       Impact factor: 5.958

4.  Moderate alcohol consumption and lipoprotein subfractions: a systematic review of intervention and observational studies.

Authors:  Trine L Wilkens; Kaare Tranæs; Jane N Eriksen; Lars O Dragsted
Journal:  Nutr Rev       Date:  2022-04-08       Impact factor: 6.846

5.  Association of High-Density Lipoprotein Particles and High-Density Lipoprotein Apolipoprotein C-III Content With Cardiovascular Disease Risk According to Kidney Function: The Multi-Ethnic Study of Atherosclerosis.

Authors:  Julio A Lamprea-Montealegre; Robyn L McClelland; James D Otvos; Samia Mora; Manja Koch; Majken K Jensen; Ian H de Boer
Journal:  J Am Heart Assoc       Date:  2019-12-10       Impact factor: 5.501

Review 6.  Dietary fat and carbohydrate affect the metabolism of protein-based high-density lipoprotein subspecies.

Authors:  Frank M Sacks; Allison B Andraski
Journal:  Curr Opin Lipidol       Date:  2022-02-01       Impact factor: 4.776

7.  New Interface for Faster Proteoform Analysis: Immunoprecipitation Coupled with SampleStream-Mass Spectrometry.

Authors:  Henrique Dos Santos Seckler; Hae-Min Park; Cameron M Lloyd-Jones; Rafael D Melani; Jeannie M Camarillo; John T Wilkins; Philip D Compton; Neil L Kelleher
Journal:  J Am Soc Mass Spectrom       Date:  2021-05-27       Impact factor: 3.262

8.  Alcohol Consumption and Risk of Dementia and Cognitive Decline Among Older Adults With or Without Mild Cognitive Impairment.

Authors:  Manja Koch; Annette L Fitzpatrick; Stephen R Rapp; Richard L Nahin; Jeff D Williamson; Oscar L Lopez; Steven T DeKosky; Lewis H Kuller; Rachel H Mackey; Kenneth J Mukamal; Majken K Jensen; Kaycee M Sink
Journal:  JAMA Netw Open       Date:  2019-09-04

9.  Associations of HDL Subspecies Defined by ApoC3 with Non-Alcoholic Fatty Liver Disease: The Multi-Ethnic Study of Atherosclerosis.

Authors:  Jakub Morze; Manja Koch; Sarah A Aroner; Matthew Budoff; Robyn L McClelland; Kenneth J Mukamal; Majken K Jensen
Journal:  J Clin Med       Date:  2020-10-31       Impact factor: 4.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.